glp-1 in the brain for Weight Loss and Diabetes Neural effects of gut‐ and

Conclusion Repurposing drugs has gained substantial attention in recent years

Nevertheless, the insulin resistance and abdominal adiposity seems to be essential in the pathophysiological process, and for this reason, based on the information available, we propose IGF-1 as a key hormone in the pathophysiology of metabolic syndrome due to its implications in the metabolism of carbohydrates and lipids

A dynamic network approach for the study of human phenotypes

The identification of PilQ/GspD as a slime nozzle is, therefore a necessary first step to allow testing these various hypotheses on the contributions of slime secretion to motility in these various bacteria

Starting July 1, 2026, Medicare will cover FDA-approved weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) for a flat $50 per month through a new initiative called the Medicare GLP-1 Bridge Program

Ahn's deep knowledge of skincare forms the foundation for scientifically-backed, highly effective products